About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNPhase 2NCT05166746

The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota

Study question: Does antibiotic alone or in combination with live biotherapeutic treatment of an abnormal vaginal microbiota improve the reproductive outcomes of IVF couples? Study hypothesis: The i...

Lead sponsor: Peter Humaidan•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Thor Haahr, MD

CONTACT

+4527885402 thohaa@rm.dk

Sponsors

Lead Sponsor

Peter Humaidan

Age

18 - 42 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Abnormal vaginal microbiota.
•The screening swab should be repeated if more than 3 months old.
•HIV, Hepatitis B or C positivity.
•First, second or third IVF stimulation cycle or embryo transfer therefrom.
•BMI\<35
•Written informed consent.

Exclusion Criteria

•Known or suspected hypersensitivity to clindamycin.
•HPV CIN 2 or higher.
•Former or current inflammatory bowel disease
•Severe concomitant disease, including diabetes.
•MAX 2 embryos may be transferred
•Artificial heart valve
•Intrauterine malformations with operation indication as determined by treating physician (Polyps, Septum, fibroma)

Related studies

RECRUITINGPhase 4

Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes

NCT07499804 · IVF, Infertility, Female

Immune Cell Populations in the Endometrium

NCT06826365 · Infertility, Female, Recurrent Miscarriage, and more

RECRUITINGPhase 4

Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET

NCT04872660 · Infertility, Female

CAPA In-vitro Oocyte Maturation

NCT06984081 · Infertility, Female

Is the AMH Intrafollicular Level a Predictor of the Ploidy Status of the Blastocyst?

NCT05837325 · Infertility, Female, Infertility

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 6, 2023Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE2

Enrollment333

Start dateDec 2017

Last updatedJul 6, 2023

Condition

Bacterial Vaginoses Infertility, Female

Locations shown

Copenhagen University Hospital, Rigshospitalet

Copenhagen

Stork Fertility Clinic VivaNeo

Copenhagen

Hvidovre Hospital, The Fertility Clinic

Hvidovre

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 6, 2023Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions